Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET. / Andersen, Katrine B.; Hansen, Allan K.; Knudsen, Karoline et al.

I: Nuclear Medicine and Biology, Bind 112-113, 01.09.2022, s. 52-58.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Andersen KB, Hansen AK, Knudsen K, Schacht AC, Damholdt MF, Brooks DJ et al. Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET. Nuclear Medicine and Biology. 2022 sep. 1;112-113:52-58. doi: 10.1016/j.nucmedbio.2022.06.007

Author

Andersen, Katrine B. ; Hansen, Allan K. ; Knudsen, Karoline et al. / Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET. I: Nuclear Medicine and Biology. 2022 ; Bind 112-113. s. 52-58.

Bibtex

@article{0c0e7df8da01402daedcee0f6da6fbe4,
title = "Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET",
abstract = "Background: The average human lifespan has increased dramatically over the past century. However, molecular and physiological alterations of the healthy brain during aging remain incompletely understood. Generalized synaptic restructuring may contribute to healthy aging and the reduced metabolism observed in the aged brain. The aim of this study was to assess healthy brain aging using [18F]FDG as a measure of cerebral glucose consumption and [11C]UCB-J PET as an indicator of synaptic density. Method: Using in vivo PET imaging and the novel synaptic-vesicle-glycoprotein 2A (SV2A) radioligand [11C]UCB-J alongside with the fluorodeoxyglucose radioligand [18F]FDG, we obtained SUVR-1 values for 14 pre-defined volume-of-interest brain regions defined on MRI T1 scans. Regional differences in relative [18F]FDG and [11C]UCB-J uptake were investigated using a voxel-wise approach. Finally, correlations between [11C]UCB-J, [18F]FDG PET, and age were examined. Results: We found widespread cortical reduction of synaptic density in a cohort of older HC subjects (N = 15) compared with young HC subjects (N = 11). However, no reduction persisted after partial volume correction and corrections for multiple comparison. Our study confirms previously reported synaptic stability during aging. Regional differences in relative [18F]FDG and [11C]UCB-J uptake were observed with up to 20 % higher [11C]UCB-J uptake in the amygdala and temporal lobe and up to 34 % higher glucose metabolism in thalamus, striatum, occipital, parietal and frontal cortex. Conclusion: In vivo PET using [11C]UCB-J does not support declining synaptic density levels during aging. Thus, loss of synaptic density may be unrelated to aging and does not seem to be a sufficient explanation for the recognized reduction in brain metabolism during aging. Our study also demonstrates that the relationship between glucose consumption and synaptic density is not uniform throughout the human brain with implications for our understanding of neuroenergetics.",
keywords = "Glucose metabolism, Healthy aging, Synaptic density, [C]UCB-J PET, [F]FDG PET",
author = "Andersen, {Katrine B.} and Hansen, {Allan K.} and Karoline Knudsen and Schacht, {Anna Christina} and Damholdt, {Malene F.} and Brooks, {David J.} and Per Borghammer",
note = "Funding Information: This work was supported by Lundbeck foundation (grant number 31391 ). Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
month = sep,
day = "1",
doi = "10.1016/j.nucmedbio.2022.06.007",
language = "English",
volume = "112-113",
pages = "52--58",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET

AU - Andersen, Katrine B.

AU - Hansen, Allan K.

AU - Knudsen, Karoline

AU - Schacht, Anna Christina

AU - Damholdt, Malene F.

AU - Brooks, David J.

AU - Borghammer, Per

N1 - Funding Information: This work was supported by Lundbeck foundation (grant number 31391 ). Publisher Copyright: © 2022 The Authors

PY - 2022/9/1

Y1 - 2022/9/1

N2 - Background: The average human lifespan has increased dramatically over the past century. However, molecular and physiological alterations of the healthy brain during aging remain incompletely understood. Generalized synaptic restructuring may contribute to healthy aging and the reduced metabolism observed in the aged brain. The aim of this study was to assess healthy brain aging using [18F]FDG as a measure of cerebral glucose consumption and [11C]UCB-J PET as an indicator of synaptic density. Method: Using in vivo PET imaging and the novel synaptic-vesicle-glycoprotein 2A (SV2A) radioligand [11C]UCB-J alongside with the fluorodeoxyglucose radioligand [18F]FDG, we obtained SUVR-1 values for 14 pre-defined volume-of-interest brain regions defined on MRI T1 scans. Regional differences in relative [18F]FDG and [11C]UCB-J uptake were investigated using a voxel-wise approach. Finally, correlations between [11C]UCB-J, [18F]FDG PET, and age were examined. Results: We found widespread cortical reduction of synaptic density in a cohort of older HC subjects (N = 15) compared with young HC subjects (N = 11). However, no reduction persisted after partial volume correction and corrections for multiple comparison. Our study confirms previously reported synaptic stability during aging. Regional differences in relative [18F]FDG and [11C]UCB-J uptake were observed with up to 20 % higher [11C]UCB-J uptake in the amygdala and temporal lobe and up to 34 % higher glucose metabolism in thalamus, striatum, occipital, parietal and frontal cortex. Conclusion: In vivo PET using [11C]UCB-J does not support declining synaptic density levels during aging. Thus, loss of synaptic density may be unrelated to aging and does not seem to be a sufficient explanation for the recognized reduction in brain metabolism during aging. Our study also demonstrates that the relationship between glucose consumption and synaptic density is not uniform throughout the human brain with implications for our understanding of neuroenergetics.

AB - Background: The average human lifespan has increased dramatically over the past century. However, molecular and physiological alterations of the healthy brain during aging remain incompletely understood. Generalized synaptic restructuring may contribute to healthy aging and the reduced metabolism observed in the aged brain. The aim of this study was to assess healthy brain aging using [18F]FDG as a measure of cerebral glucose consumption and [11C]UCB-J PET as an indicator of synaptic density. Method: Using in vivo PET imaging and the novel synaptic-vesicle-glycoprotein 2A (SV2A) radioligand [11C]UCB-J alongside with the fluorodeoxyglucose radioligand [18F]FDG, we obtained SUVR-1 values for 14 pre-defined volume-of-interest brain regions defined on MRI T1 scans. Regional differences in relative [18F]FDG and [11C]UCB-J uptake were investigated using a voxel-wise approach. Finally, correlations between [11C]UCB-J, [18F]FDG PET, and age were examined. Results: We found widespread cortical reduction of synaptic density in a cohort of older HC subjects (N = 15) compared with young HC subjects (N = 11). However, no reduction persisted after partial volume correction and corrections for multiple comparison. Our study confirms previously reported synaptic stability during aging. Regional differences in relative [18F]FDG and [11C]UCB-J uptake were observed with up to 20 % higher [11C]UCB-J uptake in the amygdala and temporal lobe and up to 34 % higher glucose metabolism in thalamus, striatum, occipital, parietal and frontal cortex. Conclusion: In vivo PET using [11C]UCB-J does not support declining synaptic density levels during aging. Thus, loss of synaptic density may be unrelated to aging and does not seem to be a sufficient explanation for the recognized reduction in brain metabolism during aging. Our study also demonstrates that the relationship between glucose consumption and synaptic density is not uniform throughout the human brain with implications for our understanding of neuroenergetics.

KW - Glucose metabolism

KW - Healthy aging

KW - Synaptic density

KW - [C]UCB-J PET

KW - [F]FDG PET

UR - http://www.scopus.com/inward/record.url?scp=85133941786&partnerID=8YFLogxK

U2 - 10.1016/j.nucmedbio.2022.06.007

DO - 10.1016/j.nucmedbio.2022.06.007

M3 - Journal article

C2 - 35820300

AN - SCOPUS:85133941786

VL - 112-113

SP - 52

EP - 58

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

ER -